Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 10 of 10 for “"mutated BRAF"”.

  1. Identification of molecular targets of oncogenic NRAs and BRAF involved in regulation of melanoma cell proliferation

    Mutated BRAF or NRAS genes have been found in ~90% of sporadic melanomas, with a frequency of ~65% of tumors harbouring a mutated BRAF and ~25% of tumors bearing an activated NRAS. However, NRAS<sup>Q61R</sup> and BRAF<sup>V600E</sup> are generally mutually exclusive, suggesting that occurrence of …

    the-open-u Download PDF for Identification of molecular targets of oncogenic NRAs and BRAF involved in regulation of melanoma cell proliferation (opens in a new tab)

  2. OXAZOLIDINONES AS A PRIVILEGED SCAFFOLD AND PRELIMINARY EVALUATION

    … scaffold to target serotonin receptor 7 (5-HT7), mutated BRAF kinase (BRAFV6000E), Bruton’s tyrosine kinase (BTK), and Cyclin-dependent protein kinase 4 and 6 (CDK4/6). Aryl piperazines and piperidines were integrated as another privileged scaffold to support the selectivity towards 5-HT7, while …

    temple Repository record for OXAZOLIDINONES AS A PRIVILEGED SCAFFOLD AND PRELIMINARY EVALUATION (opens in a new tab)

  3. Induction of Cellular Senescence As A Novel Therapeutic Strategy for Melanoma Treatment

    … senescence in human melanoma cells. Mutated BRAF or NRAS oncogenes can induce senescence in some but not all melanoma cells, whereas some small molecules are more potent triggers of premature senescence in melanoma cells than others. We established an integrated FACS approach to …

    penn Repository record for Induction of Cellular Senescence As A Novel Therapeutic Strategy for Melanoma Treatment (opens in a new tab)

  4. Conditional control of MITF reveals cellular subpopulations essential for melanoma survival and recurrence in new zebrafish models

    … each year and continually rising incidence. BRAFV600E inhibitors have led to clinically significant improvements in outcomes for melanoma patients, yet many patients with metastatic melanoma rapidly succumb to the disease due to eventual chemoresistance or insensitivity to the drug. Thus, it …

    edinburgh Repository record for Conditional control of MITF reveals cellular subpopulations essential for melanoma survival and recurrence in new zebrafish models (opens in a new tab)

  5. New insights into the KIAA1549::BRAF fusion protein and the regulation of BRAF phosphorylation at threonine 401

    … is primarily driven by a fusion of the oncogene BRAF with the relatively uncharacterised protein KIAA1549. The fusion gene results from a tandem duplication event that combines the 5' region of KIAA1549 with the 3' region of BRAF. BRAF is a well-characterised protein, that plays a pivotal role in …

    freiburg-diss Repository record for New insights into the KIAA1549::BRAF fusion protein and the regulation of BRAF phosphorylation at threonine 401 (opens in a new tab)

  6. Investigation of key non-coding and coding genes in cutaneous melanomagenesis

    … The second biomarker investigated, mutated BRAF, has been seen in 50-70% of spontaneous cutaneous melanoma. The commonest mutation in melanoma is a glutamic acid for valine substitution at position 600 (V600E). Oncogenic BRAF controls many aspects of melanoma cell biology. The aim of …

    edinburgh Repository record for Investigation of key non-coding and coding genes in cutaneous melanomagenesis (opens in a new tab)

  7. RTKs and MAPK pathway alterations in solid tumors: dissecting prognostic and therapeutic biomarkers

    … mainly driven by activating mutations on RAS and BRAF oncogenes, and more recently by RKIP protein downregulation. In the present work, in the absence of RAS and RKIP alterations, we found that MAPK pathway can be activated in KIT&PDGFRA wild-type GISTs through autocrine/paracrine mechanisms …

    minho-thes Repository record for RTKs and MAPK pathway alterations in solid tumors: dissecting prognostic and therapeutic biomarkers (opens in a new tab)

  8. Μελέτη του σηματοδοτικού μονοπατιού WNT στην καρκινογένεση

    … was performed in 55 DNA samples for KRAS, NRAS, BRAF genes of MAPK pathway, PIK3CA and AKT1 genes of PI3K/Akt pathway, CTNNB1 gene encoding β-catenin as well as the determination of MSI (microsatellite instability) status. In addition, methylation status of APC promoter was also studied in 38 …

    greece Repository record for Μελέτη του σηματοδοτικού μονοπατιού WNT στην καρκινογένεση (opens in a new tab)

  9. Antineoplastic Effects of Honokiol on Melanoma

    … against UACC-62 melanoma cell line that harbors mutated BRAF, CDK4i, PTEN and against SKMEL-2 melanoma cell line that presents NRAF, and TP53 mutated genes. For the in vivo studies, nude male mice were injected subcutaneously with 5x10 6 UACC-62 or SKMEL-2 cells. The next day animals were …

    sdstate Repository record for Antineoplastic Effects of Honokiol on Melanoma (opens in a new tab)